Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Pancreatic Neoplasms 1 Obesity, Morbid 1 Obesity 1 Fistula 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1 Colonic Neoplasms 1 Bile Duct Neoplasms 1 Anastomotic Leak 1

Interventions

Oxaliplatin 27 Fluorouracil 23 Leucovorin 22 Cetuximab 22 Bevacizumab 21 Capecitabine 16 Nivolumab 15 Irinotecan 15 pembrolizumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 encorafenib 8 Folfox protocol 7 trifluridine tipiracil drug combination 6 Ipilimumab 6 Exercise 6 Cisplatin 6 fludarabine 5 cemiplimab 5 Trastuzumab 5 Pemetrexed 5 Gemcitabine 5 Cyclophosphamide 5 Carboplatin 5 Blood Specimen Collection 5 Biopsy 5 regorafenib 4 pertuzumab 4 adagrasib 4 Trifluridine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Stents × 1 year × Clear all

NCT04450758 2026-04-23

ACBC

Skane University Hospital

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡